Forefront Wealth Management Inc. purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 547 shares of the biotechnology company's stock, valued at approximately $325,000.
Several other hedge funds also recently made changes to their positions in the company. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in Axon Enterprise during the third quarter worth about $2,162,000. PNC Financial Services Group Inc. raised its position in shares of Axon Enterprise by 17.5% in the 3rd quarter. PNC Financial Services Group Inc. now owns 5,627 shares of the biotechnology company's stock worth $2,249,000 after buying an additional 840 shares during the period. Jennison Associates LLC raised its holdings in Axon Enterprise by 48.2% in the third quarter. Jennison Associates LLC now owns 3,977 shares of the biotechnology company's stock valued at $1,589,000 after buying an additional 1,294 shares during the period. King Luther Capital Management Corp raised its holdings in shares of Axon Enterprise by 0.3% during the 3rd quarter. King Luther Capital Management Corp now owns 10,474 shares of the biotechnology company's stock valued at $4,185,000 after buying an additional 34 shares during the period. Finally, Massachusetts Financial Services Co. MA purchased a new stake in shares of Axon Enterprise during the third quarter worth about $120,553,000. Institutional investors and hedge funds own 79.08% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have recently commented on AXON. Barclays reiterated a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Morgan Stanley upgraded Axon Enterprise from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Finally, Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $604.67.
View Our Latest Analysis on AXON
Insider Activity at Axon Enterprise
In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jeri Williams sold 307 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.
Axon Enterprise Price Performance
Shares of AXON traded up $1.93 during trading hours on Tuesday, hitting $574.45. 168,009 shares of the company were exchanged, compared to its average volume of 830,239. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $44.02 billion, a PE ratio of 148.44, a PEG ratio of 5.17 and a beta of 1.12. The firm has a fifty day simple moving average of $591.98 and a 200-day simple moving average of $545.11. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.